PharmaVoice

OCTOBER 1, 2024

Mark your calendars for the most important industry conferences in 2025.

Pharma 253

Pharma 253

MedCity News

JANUARY 8, 2025

The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News. Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year.

Biopharma 306

Biopharma Medicine Marketing FDA 306

MedCity News

DECEMBER 1, 2024

in 2025 appeared first on MedCity News. Global medical costs are expected to rise by double digits for the third year in a row, according to a recent survey from WTW. The post Report: Global Medical Costs Projected to Rise by 10.4%

Medical 292

Medical Healthcare Healthcare 292

MedCity News

DECEMBER 29, 2024

The post Navigating Virtual Prescribing Policy Changes in 2025 appeared first on MedCity News. Through collaboration between regulators and healthcare stakeholders, telehealth prescribing can continue to expand treatment access while maintaining proven safety standards.

Safety 261

Safety Healthcare Healthcare Prescription 261

MedCity News

DECEMBER 16, 2024

Zocdoc CEO Oliver Kharraz has some predictions about how healthcare will change in 2025 including the rise of cash-pay services and the potential restructuring of Amazons healthcare assets. The post Zocdoc CEO Predicts 3 Ways the Healthcare Industry Will Change in 2025 appeared first on MedCity News.

Healthcare 261

Healthcare Healthcare 261

MedCity News

JANUARY 28, 2025

The MedTech industry has demonstrated remarkable resilience in navigating uncertainty, and 2025 promises to be a pivotal year as the election supercycle concludes and AI regulatory frameworks become clearer. The post 10 Key MedTech Themes for 2025 appeared first on MedCity News.

Medical 232

Medical 232

MedCity News

JANUARY 2, 2025

The post Top Priorities and Challenges for Digital Health Leaders in 2025: 5 Key Insights appeared first on MedCity News. About 79% of digital health leaders said their companies are pursuing new investment capital in the next year, according to a recent survey from Summit Health Advisors.

280

280

MedCity News

FEBRUARY 17, 2025

The post ViVE 2025: Shaping the Future of Virtual-first Care appeared first on MedCity News. Virtual care is no longer just a convenience, it is a necessity. The question is no longer whether virtual-first care is viable but how quickly we can make it the preferred model for modern healthcare.

Healthcare 226

Healthcare Healthcare Patients 226

Fierce Pharma

SEPTEMBER 30, 2024

After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound in 2025. Ahead of the CPHI conference in Milan, the events group has teased new research signaling an expected rebound for the CDMO industry—and a rejection of the BIOSECURE Act.

Biopharma 262

Biopharma 262

Fierce Pharma

NOVEMBER 8, 2024

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and | The company opted not to renew its membership for 2025 following an annual review of its trade group associations, a spokesperson said.

249

249

MedCity News

FEBRUARY 12, 2025

The post Who is Speaking at INVEST 2025? The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! appeared first on MedCity News.

Networking 162

Networking Healthcare Healthcare Medical 162

MedCity News

FEBRUARY 21, 2025

The post ViVE 2025: The Crossroads of Digital Health Innovation and Realities appeared first on MedCity News.

185

185

Fierce Pharma

DECEMBER 17, 2024

After pulling off a surprise third-quarter beat and full-year guidance raise amid shareholder activism earlier this year, Pfizer now expects its 2025 revenues to come in the same range as in 2024.<

194

194

MedCity News

JANUARY 24, 2025

Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World appeared first on MedCity News. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world.

Pharma 233

Pharma Leads Biopharma 233

Fierce Pharma

JULY 25, 2023

In a sizable cost-cutting measure, Biogen will lay off 1,000 employees by 2025, it announced in presenting its second quarter earnings. In reporting its first-quarter earnings, Biogen said it would halt the development of at least four investigational drugs to allow the company to focus on more lucrative opportunities. |

216

216

Fierce Pharma

MAY 29, 2024

first Humira biosim launch last year and its planned Stelara biosim rollout in 2025. first Humira biosim launch last year and its planned Stelara biosim rollout in 2025. Amgen has made waves in the biosimilar field in recent years with its U.S.-first Amgen has made waves in the biosimilar field in recent years with its U.S.-first

FDA 173

FDA 173

MedCity News

FEBRUARY 4, 2025

The post Tips for Greater Healthcare Practice Success in 2025 appeared first on MedCity News. [Sponsored] Hidden costs can undermine your healthcare practice. A webinar sponsored by Elation Health will offer insights on how to address them.

Healthcare 162

Healthcare Healthcare 162

MedCity News

FEBRUARY 25, 2025

[Sponsored] Executives from EY, Genzeon, ProviderTrust, SmarterDx, and symplr shared insights about their businesses in interviews at the ViVE 2025 conference in Nashville this month. The post The Vibe at ViVE: Health Tech Leaders Discuss Plans for 2025 appeared first on MedCity News.

130

130

PharmaVoice

JANUARY 6, 2025

How regulators could hit PBMs from multiple sides in the coming year.

325

325

MedCity News

OCTOBER 29, 2024

As companies begin to make plans for 2025, add the INVEST Pitch Perfect Contest to your calendar. The post Are You a Startup Looking for an Audience of Investors? We Have The Perfect Pitch Contest for You! appeared first on MedCity News.

Biopharma 293

Biopharma 293

MedCity News

JANUARY 30, 2025

Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. Phase 2 data for Cargo Therapeutics CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events.

Prospecting 285

Prospecting Safety Leads Biopharma 285

Impetus Digital

DECEMBER 23, 2024

Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders.

Education 112

Education Medical Pharma Training 112

Fierce Pharma

MAY 28, 2024

A recently announced $900 million restructuring drive is already making waves at Takeda, wi | From early July to March 2025, the Japanese drugmaker will cut 495 staffers at its Cambridge location and 146 in Lexington, Massachusetts. Takeda is the largest life sciences employer in the state.

304

304

MedCity News

APRIL 18, 2024

Included Health’s new specialty care clinic, which will become available in 2025, is starting by offering three centers: the Cancer Center, the Center for Women’s Health and the Center for Metabolic Health. The post Included Health Announces New Specialty Care Offering appeared first on MedCity News.

305

305

MedCity News

APRIL 2, 2024

America’s Health Insurance Plans, the Better Medicare Alliance and the Association for Community Affiliated Plans all came out against CMS’ final 2025 Medicare Advantage and Part D rate announcement. The post Insurer Advocacy Orgs Slam Final MA, Part D Rate Announcement appeared first on MedCity News.

Insurance 301

Insurance 301

MedCity News

OCTOBER 23, 2024

In a series of articles to promote INVEST 2025 in Chicago April 29-30, we are highlighting investment insights and perspectives in the runup to the boutique event for traditional and strategic healthcare investors and startups. Register today!

Healthcare 267

Healthcare Healthcare 267

Fierce Pharma

APRIL 23, 2024

The recent Big Pharma CEO, known for steering the $74 billion acquisition of Celgene, has been proposed as the new chair at Novartis for 2025. . | Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March.

Pharma 314

Pharma 314

MedCity News

DECEMBER 10, 2024

In a letter, Families USA and numerous other organizations called on Congress to extend the enhanced premium tax credits that are set to expire at the end of 2025. The post More Than 70 Organizations Urge Congress to Extend Enhanced Premium Tax Credits appeared first on MedCity News.

300

300

MedCity News

NOVEMBER 1, 2024

and European Union approvals in this indication in 2025. Novo Nordisk’s Wegovy achieved statistically significant improvement in a Phase 3 study in the fatty liver disease MASH. Based on these preliminary results, the company plans to seek U.S.

FDA 280

FDA Biopharma Pharma 280

Fierce Pharma

SEPTEMBER 12, 2024

Gilead Sciences is no stranger to making history in HIV. | In a study of more than 3,000 participants, Gilead's twice-yearly lenacapavir delivered a 96% reduction in HIV infections compared with background HIV incidence.

294

294

PharmaVoice

MARCH 10, 2025

Familiar foes in the industry have claimed a slew of jobs in recent months.

162

162

MedCity News

JANUARY 16, 2023

A budget estimate attached to proposed legislation in Montana raises questions about whether the state’s cash-strapped communities will have the capacity to care for patients with Alzheimer’s disease, other types of dementia or traumatic brain injuries by July 2025, when involuntary commitments would cease under the plan.

Patients 322

Patients 322

MedCity News

DECEMBER 19, 2023

Both partners expect to complete the product’s FDA submission by 2025.

Networking 321

Networking FDA 321

MedCity News

SEPTEMBER 20, 2024

representatives and senators called for an extension of the enhanced premium tax credits, which are set to expire in 2025 and have lowered costs for those purchasing coverage on the marketplace. In two letters, U.S. The post 195 Congress Members Call for Extension of Enhanced Premium Tax Credits appeared first on MedCity News.

292

292

Pharmaceutical Technology

FEBRUARY 24, 2025

PHARMAP 2025 takes place on 14-15 April 2025 in Berlin, Germany.

Manufacturing 96

Manufacturing 96

MedCity News

APRIL 22, 2024

In 2025, the task force will release a blueprint of actionable recommendations on how employers can improve their coverage. The Commonwealth Fund recently launched the National Task Force on the Future Role of Employers in the U.S. Health System.

Insurance 292

Insurance 292